[Clinical use of peripheral stem cells for autologous transplantation].
Peripheral blood derived hematopoietic stem cells (PBSC) have been transplanted successfully to eight patients suffering from different malignancies. The separations were started during chemotherapy-induced cytopenia and large volumes of peripheral blood were processed. Using this separation concept, it was possible in all cases to obtain the stem cell amount necessary for hematopoietic reconstitution.
Zingsem
J
J
Abteilung Innere Medizin und Poliklinik m.S. Hämatologie und Onkologie, Universitätsklinikum Rudolf Virchow, Berlin.
Zeiler
T
T
Weisbach
V
V
Holfeld-Ozuysal
C
C
Zimmermann
R
R
Heuft
H G
HG
Beyer
J
J
Schwerdtfeger
R
R
Eckstein
R
R
D001772:Blood Cell Count; D016913:Blood Component Transfusion / Q000295:instrumentation*; D001804:Blood Transfusion, Autologous / Q000295:instrumentation*; D016026:Bone Marrow Transplantation / Q000295:instrumentation; D003114:Colony-Forming Units Assay; D004867:Equipment Design; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007938:Leukemia / Q000097:blood / Q000628:therapy*; D008223:Lymphoma / Q000097:blood / Q000628:therapy*; D008297:Male; D013736:Testicular Neoplasms / Q000097:blood / Q000628:therapy*
Klinischer Einsatz peripherer Stammzellen zur autologen Transplantation.